Mendelian Reports High Cost of Rare Disease Patients
New research commissioned by health tech company Mendelian found that rare disease patients have cost NHS England in excess of £4.3bn over the past ten years. The company is hoping its technology can enable physicians and hospitals to save money and diagnose patients faster.
You may also be interested in...
Belgian start-up miDiagnostics has closed a €14m investment round to accelerate development of its silicon-chip-based diagnostics platform. The company believes the blood analyzer could deliver rapid test results in multiple settings.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
The UK government has ordered 3.5 million home test kits to identify people who have antibodies to the SARS-CoV-2 virus. However, it has not said who will supply the test kits.